Top

Journal of Cancer Education

Published in:

01-03-2011 | Letter to the Editor

Physician Awareness and Referral to National Smoking Cessation Quitlines and Web-Based Resources

Authors: Lila J. Finney Rutten, Kia Davis, Linda Squiers, Erik Augustson, Kelly Blake

Published in: Journal of Cancer Education | Issue 1/2011

Excerpt

Dear Editor, …

Stead LF, Perera R, Lancaster T (2007) A systematic review of interventions for smokers who contact quitlines. Tob Control 16(Suppl 1):3–8CrossRef

PHS Guideline Update Panel, Liaisons, and Staff (2008) Treating tobacco use and dependence: 2008 update U.S. public health service clinical practice guideline executive summary. Respir Care 53(9):1217–1222

Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW (2009) Colorectal cancer screening by primary care physicians: recommendations and practices, 2006–2007. Am J Prev Med 37(1):8–16CrossRefPubMed

Cokkinides VE, Halpern MT, Barbeau EM, Ward E, Thun MJ (2008) Racial and ethnic disparities in smoking-cessation interventions: analysis of the 2005 national health interview survey. Am J Prev Med 34(5):404–412CrossRefPubMed

Lopez-Quintero C, Crum RM, Neumark YD (2006) Racial/ethnic disparities in report of physician-provided smoking cessation advice: analysis of the 2000 national health interview survey. Am J Public Health 96(12):2235–2239CrossRefPubMed

Sonnenfeld N, Schappert SM, Lin SX (2009) Racial and ethnic differences in delivery of tobacco-cessation services. Am J Prev Med 36(1):21–28CrossRefPubMed

Steinberg MB, Alvarez MS, Delnevo CD, Kaufman I, Cantor JC (2006) Disparity of physicians’ utilization of tobacco treatment services. Am J Health Behav 30(4):375–386PubMed

Title: Physician Awareness and Referral to National Smoking Cessation Quitlines and Web-Based Resources
Authors: Lila J. Finney Rutten
Kia Davis
Linda Squiers
Erik Augustson
Kelly Blake
Publication date: 01-03-2011
Publisher: Springer-Verlag
Published in: Journal of Cancer Education / Issue 1/2011
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI: https://doi.org/10.1007/s13187-010-0163-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2011

Understanding the Processes of Patient Navigation to Reduce Disparities in Cancer Care: Perspectives of Trained Navigators from the Field

Knowledge and Attitudes Regarding Colorectal Cancer Screening Among Medical Students: A Tale of Two Schools

Effective Teaching Strategies and Methods of Delivery for Patient Education: A Systematic Review and Practice Guideline Recommendations

The Wisdom of Experience: Becoming an Effective Principal Investigator

Teaching Advance Care Planning to Medical Students with a Computer-Based Decision Aid

The Art and Science of Cancer Education and Evaluation: Toward Facilitating Improved Patient Outcomes

Keynote webinar | Spotlight on antibody–drug conjugates in cancer